Russia’s Pavlyuchenkova reaches Australian Open quarterfinalsSport January 22, 7:19
IBU Executive Board finds no grouns to suspend Russia's biathlon teamSport January 21, 22:53
Russia terrified watching monuments destroyed in Palmyra — culture ministerRussian Politics & Diplomacy January 21, 17:08
Russian bombers deliver successfully strikes on terrorists' facilities in SyriaWorld January 21, 15:39
Denmark uses Russian data in its application for expanding shelf — ministerBusiness & Economy January 21, 15:15
Agreement on bases in Syria to serve strengthening of stability in Middle East — MPRussian Politics & Diplomacy January 20, 21:18
Trump's inaugural address: When America is united, America is totally unstoppableWorld January 20, 20:57
Hermitage chief: New Palmyra destruction comes across as militants' vengeanceRussian Politics & Diplomacy January 20, 20:29
Russia's first deputy PM wants to keep current tax system for next political cycleBusiness & Economy January 20, 19:53
“At the virology center of the Defense Ministry’s Microbiology Research Institute in Sergiyev Posad (Moscow region) and at the Vektor Center for Virology and Biotechnologies in Novosibirsk, vaccines are ready," Valery Chereshnev, chairman of the State Duma’s parliamentary committee on science and technologies and member of the Skolkovo Innovation Center Scientific Council said Monday.
Hopes in the fight against Ebola also lay in Triazaverine, a medicine developed by scientists at the Urals branch of the Academy of Sciences jointly with specialists of the Health Ministry’s Institute for Influenza Studies and the Urals University. Ministry officials have approved the medicine's use, Chereshnev said .“The medicine’s authors have not checked its effect against Ebola but against various lines of flu viruses it has proved to work very actively: great medicine it is,” he added.
“Triazaverine has not been tested against the Ebola virus as the disease was registered only rarely in the past,” one of the medicine's formulators, Academician Oleg Chupakhin, told TASS. Triazaverine had generated good results against 15 forms of flu, including A/H1N1 (swine flu) and H5N1 (avian flu) at any stage of the disease, he said.
Academician Chereshnev said current measures to protect Russia from Ebola are sufficient.
“All people with symptoms of acute respiratory infection are stopped at airports and undergo blood tests," he said. "It is quite realistic to have a final diagnosis within several days. Checking people at airports is effective and the practice is used globally.
Russian Healthcare Minister Veronika Skrovtsova said on Monday that six months will be needed to prepare Russian Ebola vaccine for clinical trials.